The price drop is not due to shorters. The stock is over-valued. The market, which is a forward looking mechanism for determining price, is re-pricing the stock based on the fact that Resmed missed growth expectations.
Going forward, the market no longer believes that a P/E ration of 35 is justifiable. Resmed is growing nicely, but it's now growing enough to sustain a $16+ share price.
My greed got the better of me on this one, and I jumped in on Friday when the stock dropped 12%, without properly looking at the company. Now that I have looked at it properly, it looks overpriced. I bought more today to average down, but I think I'm going to have to hold this stock for sometime before I see it break-even.
So I've changed my sentiment from Buy to Hold. Good luck to all!
The price drop is not due to shorters. The stock is over-valued....
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
